New statement released by anticoagulation forum

New statement released by anticoagulation forum
The Anticoagulation Forum has endorsed a new consensus statement aimed at optimizing the delivery of anticoagulation therapy to inpatients; the statement has been published in the May issue of the Annals of Pharmacotherapy.

(HealthDay)—The Anticoagulation Forum has endorsed a new consensus statement aimed at optimizing the delivery of anticoagulation therapy to inpatients; the statement has been published in the May issue of the Annals of Pharmacotherapy.

Edith A. Nutescu, Pharm.D., from the University of Illinois at Chicago, and colleagues from the Anticoagulation Forum reviewed the medical literature to identify published articles relating to the standards of practice, national guidelines, patient safety initiatives, and regulatory requirements pertaining to anticoagulant use in the inpatient setting.

The recommendations endorsed by the Anticoagulation Forum and included in the statement are aimed at informing the development of coordinated care systems containing elements with demonstrated benefit in improvement of outcomes. The paper addresses the areas of process, accountability, integration, standards of practice, provider education and competency, patient education, care transitions, and outcomes.

"This document provides consensus guidelines for anticoagulant therapy in the inpatient setting and serves as a companion document to prior guidelines relevant for outpatients," the authors write.

More information: Abstract
Full Text

add to favorites email to friend print save as pdf

Related Stories

New blood-thinner measures may cut medication errors

May 22, 2013

Blood thinners are the preferred treatment option to prevent heart attacks, blood clots and stroke, but they are not without risk, and not just because of their side effects. These high-risk drugs, known as anticoagulants, ...

Recommended for you

Have a cold? Don't ask your doctor for antibiotics

Nov 26, 2014

Antibiotic resistance is a major threat to public health. Resistance makes it harder for physicians to treat infections and can increase the chance patients will die from an infection. What is more, the treatment ...

Powdered measles vaccine found safe in early clinical trials

Nov 25, 2014

A measles vaccine made of fine dry powder and delivered with a puff of air triggered no adverse side effects in early human testing and it is likely effective, according to a paper to be published November 28 in the journal ...

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.